Lv2
154 积分 2023-03-06 加入
Beyond Ozempic: brand-new obesity drugs will be cheaper and more effective
15天前
已完结
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
22天前
已完结
Route Development toward a Pyrazine Building Block to Enable Early Scale-Up Campaigns
27天前
已完结
Etripamil Nasal Spray: Therapeutic Potential for Treating Paroxysmal Supraventricular Tachycardia
1个月前
已关闭
Innovative pharmacological approaches to hypertrophic cardiomyopathy: The emerging role of Aficamten
1个月前
已完结
How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA
1个月前
已完结
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors
1个月前
已完结
Development and Scale-Up of an Improved Manufacturing Route to the ATR Inhibitor Ceralasertib
2个月前
已完结
Akt Pathway Inhibitors
2个月前
已完结
Development of a Manufacturing Route toward AMG 193, an MTA-Cooperative PRMT5 Inhibitor
2个月前
已完结
皖公网安备34019202002308
